Screener
Haemonetics HAE CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 |
|---|---|---|
| Change in accounts payable and accrued expenses | (12,615) | (47,896) |
| Net cash provided by operating activities | 52,323 | 17,395 |
| Cash Flows from Investing Activities: | ||
| Capital expenditures | (7,906) | (3,754) |
| Non-cash transfers from inventory to property, plant and equipment for Haemonetics equipment | (5,565) | (11,460) |
| Proceeds from sale of property, plant and equipment | 237 | 297 |
| Other investments | (9,000) | (18,083) |
| Net cash used in investing activities | (22,234) | (33,000) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Haemonetics's capex?
- Haemonetics (HAE) reported capex of $7.91M in Q2 2026.
- How has Haemonetics's capex changed year-over-year?
- Haemonetics's capex increased by 110.6% year-over-year, from $3.75M to $7.91M.
- What is the long-term trend for Haemonetics's capex?
- Over 4 years (2022 to 2026), Haemonetics's capex has grown at a -23.7% compound annual growth rate (CAGR), from $96.51M to $32.78M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Haemonetics's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude